Elizabeth T Dolan

Summary

Publications

  1. pmc Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions
    Deborah L Reichart
    Research Division, Procter and Gamble, Mason, OH, USA
    BMC Musculoskelet Disord 12:27. 2011
  2. pmc Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals
    Richard T Hinkle
    Research Division, Procter and Gamble Company, Mason, OH, USA
    BMC Musculoskelet Disord 12:15. 2011

Detail Information

Publications2

  1. pmc Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions
    Deborah L Reichart
    Research Division, Procter and Gamble, Mason, OH, USA
    BMC Musculoskelet Disord 12:27. 2011
    ..Thus we hypothesize that activation of the dopamine 1 and/or 5 receptor will increase skeletal muscle cAMP levels thereby modulating skeletal muscle mass and force production...
  2. pmc Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals
    Richard T Hinkle
    Research Division, Procter and Gamble Company, Mason, OH, USA
    BMC Musculoskelet Disord 12:15. 2011
    ..Corticotrophin releasing factor 2 receptor (CRF2R) agonists have been shown to maintain skeletal muscle mass and force production in a variety of acute conditions that lead to skeletal muscle wasting...